Alpa Laboratories Limited (NSE:ALPA)

Market Cap	1.47B -33.6%
Revenue (ttm)	1.22B +8.1%
Net Income	150.10M -23.0%
EPS	2.61 -71.9%
Shares Out	21.04M
PE Ratio	26.75
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	81,144
Open	72.50
Previous Close	71.42
Day's Range	68.50 - 73.00
52-Week Range	46.10 - 108.30
Beta	0.96
Analysts	n/a
Price Target	n/a
Earnings Date	May 29, 2026

About Alpa Laboratories

Alpa Laboratories Limited engages in the manufacture and sale of drugs and chemicals in India. It provides formulations that address various therapeutic segments. The company was incorporated in 1988 and is based in Indore, India.

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1988
• Employees: 453
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: ALPA

Financial Performance

In fiscal year 2026, Alpa Laboratories's revenue was 1.22 billion, an increase of 8.11% compared to the previous year's 1.12 billion. Earnings were 150.10 million, a decrease of -23.04%.